Logo

AN INNOVATIVE
PHARMACEUTICAL COMPANY

WITH GROUNDBREAKING PATENTS

Type something to start searching.

LATEST NEWS

 CEO's Statement – Spring 2025

CEO's Statement – Spring 2025

2025/04/14

 Peter Åberg Appointed as the New CEO of Auxesis Pharma Holding AB (publ)

Peter Åberg Appointed as the New CEO of Auxesis Pharma Holding AB (publ)

2025/02/15

Auxesis Pharma Has Applied for an International Patent

Auxesis Pharma Has Applied for an International Patent

2024/11/29

AUXESIS PHARMA – RESEARCH AND INNOVATION FOR LOCAL PAIN RELIEF AND SKIN HEALTH

Auxesis Pharma is a publicly traded company dedicated to developing innovative pharmaceuticals for the treatment of localized pain and skin irritation in both humans and animals. With a strong foundation in research and development, the company strives to deliver solutions that enhance quality of life and address specific market needs.

Our strength lies in our extensive expertise in science and technology, combined with an experienced leadership team that possesses a deep understanding of both the industry and market dynamics.

Auxesis Pharma is committed to continuously developing sustainable and effective solutions based on scientific principles.

DIFFERENT TYPES OF PAIN

Pain can manifest in different ways depending on its cause and intensity. It can range from mild discomfort, such as itching or irritation from insect bites, to more intense sensations like burning, stinging, or swelling caused by venomous stings or injuries. In humans, pain can often be described and treated effectively, whereas in animals, the expressions of pain vary, making diagnosis and management more challenging.

Mosquitos
Jellyfish
Pets
Wasp
Children
Livestock

FINANCIAL INFORMATION

Here, we provide information for partners and investors, including news and updates from Auxesis Pharma.

Euroclear

Euroclear

AUXESIS PHARMA HOLDING AB (publ) is now a registered company with Euroclear Sweden AB as its securities institution. Read more about all our goals here.

Annual General Meeting Minutes

Annual General Meeting Minutes

Minutes from the 2023 Annual General Meeting of AUXESIS PHARMA HOLDING AB (publ), organization number 559195-6486

Auditor’s Report 2023

Auditor’s Report 2023

Auditor’s report for 2023 for AUXESIS PHARMA HOLDING AB (publ), organization number 559195-6486.

© Copyright EDUFREE 2022
Developed by EnterCode Sweden AB